Jessen, Walter J <br/><br/>
MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.  [electronic resource] 

 -  The Journal of clinical investigation  Jan 2013 
 - 340-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, American Recovery and Reinvestment Act; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1558-8238 
<br/><br/><label>Standard No.: </label>10.1172/JCI60578  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Benzamides--pharmacology<br/>Child<br/>Child, Preschool<br/>Diphenylamine--analogs & derivatives<br/>Extracellular Signal-Regulated MAP Kinases--genetics<br/>Female<br/>Humans<br/>Male<br/>Mice<br/>Mice, Mutant Strains<br/>Mitogen-Activated Protein Kinase Kinases--antagonists & inhibitors<br/>Neoplasm Transplantation<br/>Neurofibromatosis 1--drug therapy<br/>Oncogene Protein p21(ras)--genetics<br/>Peripheral Nervous System Neoplasms--drug therapy<br/>Transcriptome--drug effects<br/>Transplantation, Heterologous<br/>Xenograft Model Antitumor Assays<br/>raf Kinases--genetics